Pneumomediastinum as a presenting feature of allergic bronchopulmonary aspergillosis in a child with cystic fibrosis.
University of Nottingham, QMC Campus, Derby Road, Nottingham NG7 2UH, UK. harish.sutrave@nuh.nhs.uk
Harish
H
Sutrave
Amanda
A
Ward
Alan R
AR
Smyth
Jayesh
J
Bhatt
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001229:Aspergillosis, Allergic Bronchopulmonary / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D003937:Diagnosis, Differential; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008478:Mediastinal Emphysema / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy; D008991:Monitoring, Physiologic / Q000379:methods; D012129:Respiratory Function Tests; D018570:Risk Assessment; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents